￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

Ceritinib is effective in first-line treatment of crizotinib-resistant lung cancer patients

2025-10-19 11:44:20

Check Details
Ceritinib can be used to treat patients with non-small cell lung cancer who have progressed or are intolerant to crizotinib_ Kanghule

2025-10-19 11:44:20

Check Details
Efficacy of Xalkori (crizotinib) in patients with ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Treatment of Xalkore (crizotinib) in patients with advanced ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Crizotinib (Xalkori) is suitable for ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Entrectinib has long-term clinical efficacy in ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
[Clinical Observation] Xakori (crizotinib) is effective in ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Will the lung cancer targeted drug Gitare be reimbursed by medical insurance? If you want to know, hurry up

2025-10-19 11:44:20

Check Details
What is the out-of-pocket rate for Gyterinib (afatinib)? Everything everyone cares about is here

2025-10-19 11:44:20

Check Details
[New Social Security Regulations] How much can Gefitinib save after medical insurance in 2021?

2025-10-19 11:44:20

Check Details
Will the targeted drug afatinib be reimbursed by medical insurance? List of targeted drugs reimbursed by medical insurance

2025-10-19 11:44:20

Check Details
The greater the side effects of the targeted drug gefitinib, the better the effect? Oncology experts see it this way

2025-10-19 11:44:20

Check Details
Category
相关知识